Concentrix Q1 Earnings Call Highlights

Valentine attributed the healthcare diminution to lighter volumes than expected, “largely related to changes successful Medicare membership” for immoderate clients and information successful Affordable Care Act programs. He said helium did not expect that vertical to instrumentality to maturation “for a mates of quarters.”

For exertion and user electronics, Valentine said the diminution reflected a operation of little underlying volumes, immoderate interaction from automation, and offshore mix. He characterized the vertical arsenic having shown volatility implicit the past 8 quarters and said it “could spell up oregon down” successful the 2nd fractional of fiscal 2026 depending connected the pipeline and stock gains wrong the lawsuit base.

→ Active ETFs Surge Past Passive, and These Are successful the Lead

On profitability, Valentine reported non-GAAP operating income of $295 million, which helium said was the midpoint of the company’s anterior guidance range. Adjusted EBITDA was $348 million, representing a 13.9% margin. Non-GAAP diluted EPS was $2.61, which absorption said was successful enactment with the guidance scope provided successful January.

GAAP results included a $6 cardinal nonaccomplishment related to the merchantability of 2 tiny non-strategic businesses. One merchantability closed during the quarter, portion the 2nd is expected to adjacent aboriginal successful the year; the pending sale’s assets and liabilities were classified arsenic held for merchantability connected the equilibrium sheet. Total nett proceeds from the 2 divestitures are expected to beryllium astir $20 million.